Nasal allergies in the Latin American population: Results from the Allergies in Latin America survey

Allergy and Asthma Proceedings

Volumn 31, Issue SUPPL. 1, 2010, Pages

  Neffen, Hugo ^a   Mello Jr , Joao F ^b   Sole, Dirceu ^b   Naspitz, Charles K ^c   Dodero, Alberto Eduardo ^d   Garza, Héctor León ^e,f   Guerra, Edgard Novelo ^g   B́aez Loyola, Carlos ^e   Boyle, John M ^h   Wingertzahn, Mark A ⁱ  

^a 'O Alassia' Children's Hospital   (Argentina)

^b UNIVERSITY OF SÃO PAULO   (Brazil)

^c FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

^d HOSPITAL DE CLÍNICAS JOSÉ DE SAN MARTÍN   (Argentina)

^e UNIVERSIDAD NACIONAL AUTÓNOMA DE MÉXICO   (Mexico)

^f Mexican Association for Respiratory Care   (Mexico)

^g HOSPITAL ÁNGELES LOMAS   (Mexico)

^h Universidad Nacional Autonoma de Mexico ^*  (United States)

ⁱ Nycomed GmbH   (United States)

Author keywords

Allergic rhinitis; Efficacy; Intranasal corticosteroids; Nasal allergies; Nasal allergy medications; Productivity; Quality flife; Safety; Sleep; Survey

Indexed keywords

CORTICOSTEROID; NON PRESCRIPTION DRUG; NOSE SPRAY; PRESCRIPTION DRUG; ANTIALLERGIC AGENT;

ADOLESCENT; ADULT; ARGENTINA; ARTICLE; BRAZIL; CHILD; CHILE; COLOMBIA; ECUADOR; FEMALE; GENERAL PRACTITIONER; HEALTH SURVEY; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL SPECIALIST; MEXICO; NOSE ALLERGY; NOSE CONGESTION; PATIENT SATISFACTION; PERU; PREVALENCE; PRODUCTIVITY; QUALITY OF LIFE; VENEZUELA; INFORMATION PROCESSING; RHINITIS, ALLERGIC, PERENNIAL; RHINITIS, ALLERGIC, SEASONAL; SOUTH AND CENTRAL AMERICA;

ADOLESCENT; ANTI-ALLERGIC AGENTS; CHILD; DATA COLLECTION; HUMANS; LATIN AMERICA; PATIENT SATISFACTION; QUALITY OF LIFE; RHINITIS, ALLERGIC, PERENNIAL; RHINITIS, ALLERGIC, SEASONAL;

EID: 77955878721     PISSN: 10885412     EISSN: 15396304     Source Type: Journal    
DOI: 10.2500/aap.2010.31.3347     Document Type: Article

References (42)

1. Storms W. Allergic rhinitis-induced nasal congestion: Its impact on sleep quality. Prim Care Respir J. 17:7-18, 2008. (Pubitemid 351416287)
2. Meltzer EO. Allergic rhinitis: Managing the pediatric spectrum. Allergy Asthma Proc 27:2-8, 2006. (Pubitemid 43440058)
3. Björkstén B, Clayton T, Ellwood P, et al., and ISAAC Phase III Study Group. Worldwide time trends for symptoms of rhinitis and conjunctivitis: Phase III of the International Study of Asthma and Allergies in Childhood. Pediatr Allergy Immunol 19:110-124, 2008.
4. Meltzer EO, Blaiss MS, Derebery MJ, et al. Burden of allergic rhinitis: Results from the Pediatric Allergies in America survey. J Allergy Clin Immunol 124:S43-S70, 2009.
5. Meltzer EO, Nathan R, Derebery J, et al. Sleep, quality of life, and productivity impact of nasal symptoms in the United States: Findings from the Burden of Rhinitis in America survey. Allergy Asthma Proc 30:244-254, 2009.
6. Blaiss M, Meltzer EO, Derebery MJ, and Boyle JM. Patient and healthcare-provider perspectives on the burden of allergic rhinitis. Allergy Asthma Proc 28:S4-S10, 2007.
7. Reed SD, Lee TA, and McCrory DC. The economic burden of allergic rhinitis: A critical evaluation of the literature. Pharmacoeconomics 22:345-361, 2004. (Pubitemid 38609812)
8. Schoenwetter WF, Dupclay L Jr, Appajosyula S, et al. Economic impact and quality-of-life burden of allergic rhinitis. Curr Med Res Opin 20:305-317, 2004. (Pubitemid 38344119)
9. Benninger M. Diagnosis and management of nasal congestion: The role of intranasal corticosteroids. Postgrad Med 121:122-131, 2009.
10. Tripathi A, and Patterson R. Impact of allergic rhinitis treatment on quality of life. Pharmacoeconom 19:891-899, 2001.
11. Meltzer EO. Quality of life in adults and children with allergic rhinitis. J Allergy Clin Immunol 108:S45-S53, 2001.
12. McDonald K, Trick L, and Boyle J. Sedation and antihistamines: An update. Review of inter-drug differences using proportional impairment ratios. Hum Psychopharmacol 23:555-570, 2008.
13. Blaiss MS. Allergic rhinitis and impairment issues in schoolchildren: A consensus report. Allergic Rhinitis in Schoolchildren Consensus Group. Curr Med Res Opin 20:1937-1952, 2004.
14. Soldovieri MV, Miceli F, and Taglialatela M. Cardiotoxic effects of antihistamines: From basics to clinics (.and back). Chem Res Toxicol 21:997-1004, 2008.
15. Marple BF. Targeting congestion in allergic rhinitis: The importance of intranasal corticosteroids. Allergy Asthma Proc 29:232-240, 2008.
16. Weiner JM, Abramson MJ, and Puy RM. Intranasal corticosteroids versus oral H1 receptor antagonists in allergic rhinitis: Systematic review of randomized controlled trials. Brit Med J 317:1624-1629, 1998.
17. White P, Smith H, Baker N, et al. Symptom control in patients with hay fever in UK general practice: How well are we doing and is there a need for allergen immunotherapy? Clin Exp Allergy 28:266-270, 1998.
18. Scadding GK, Richards DH, and Price MJ. Patient and physician perspectives on the impact and management of perennial and seasonal allergic rhinitis. Clin Otolaryngol Allied Sci 25:551-557, 2000.
19. Bachert C, and El-Akkad T. Patient preferences and sensory comparisons of three intranasal corticosteroids for the treatment of allergic rhinitis. Ann Allergy Asthma Immunol 89:292-297, 2002.
20. Mahadevia P, Shah S, Mannix S, et al. Willingness to pay for sensory attributes of intranasal corticosteroids among patients with allergic rhinitis. J Manag Care Pharm 12:143-151, 2006.
21. Meltzer E, Bardelas J, Goldsobel A, and Kaiser H. A preference evaluation study comparing the sensory attributes of mometasone furoate and fluticasone propionate nasal sprays by patients with allergic rhinitis. Treat Respir Med 4:289-296, 2005.
22. Neffen H, Sole D, and Maspero J. Rinitis alérgica en Latinoamérica. Manejo actual y estratrategias para la adopción de guías de diagnostico y tratamiento. Drugs Today 45:1-19, 2009.
23. Schatz M, Zeiger RS, Chen W, et al. The burden of rhinitis in a managed care organization. Ann Allergy Asthma Immunol 101:240-247, 2008.
24. Nathan RA, Meltzer EO, Derebery J, et al. The prevalence of nasal symptoms attributed to allergies in the United States: Findings from the burden of rhinitis in an America survey. Allergy Asthma Proc 29:600-608, 2008.
25. HealthSTAR Communications, Inc., in partnership with Schulman, Ronca and Bucuvalas, Inc. Pediatric Allergies in America: A Landmark Survey of Nasal Allergy Sufferers. Executive Summary, Florham Park, NJ: Altana Pharma US, Inc., 1-32, 2007.
26. Berger WE. Overview of allergic rhinitis. Ann Allergy Asthma Immunol 90:7-12, 2003.
27. Keith PK, Desrosiers M, Waserman S, and Schellenberg RR. Burden of illness of allergic rhinitis in Canada. J Allergy Clin Immunol 119:S356, 2007.
28. Santos CB, Hanks C, McCann J, et al. The role of montelukast on perennial allergic rhinitis and associated sleep disturbances and daytime somnolence. Allergy Asthma Proc 29:140-145, 2008.
29. Ciprandi G, Klersy C, Cirillo I, and Marseglia GL. Quality of life in allergic rhinitis: Relationship with clinical, immunological, and functional aspects. Clin Exp Allergy 37:1528-1535, 2007.
30. Szeinbach SL, Seoane-Vazquez EC, Beyer A, and Williams PB. The impact of allergic rhinitis on work productivity. Prim Care Respir J 16:98-105, 2007.
31. Nathan RA. The burden of allergic rhinitis. Allergy Asthma Proc 28:3-9, 2007.
32. Craig TJ, Ferguson BJ, and Krouse JH. Sleep impairment in allergic rhinitis, rhinosinusitis, and nasal polyposis. Am J Otolaryngol 29:209-217, 2008.
33. Pratt EL, and Craig TJ. Assessing outcomes from the sleep disturbance associated with rhinitis. Curr Opin Allergy Clin Immunol 7:249-256, 2007.
34. Stull DE, Roberts L, Frank L, and Heithoff K. Relationship of nasal congestion with sleep, mood, and productivity. Curr Med Res Opin 23:811-819, 2007.
35. Kakumanu S, Glass C, and Craig T. Poor sleep and daytime somnolence in allergic rhinitis: Significance of nasal congestion. Am J Respir Med 1:195-200, 2002.
36. Santos CB, Pratt EL, Hanks C, et al. Allergic rhinitis and its effect on sleep, fatigue, and daytime somnolence. Ann Allergy Asthma Immunol 97:579-586, 2006.
37. Ferguson BJ. Influences of allergic rhinitis on sleep. Otolaryngol Head Neck Surg 130:617-629, 2004.
38. Craig TJ, McCann JL, Gurevich F, and Davies MJ. The correlation between allergic rhinitis and sleep disturbance. J Allergy Clin Immunol 114:S139-S145, 2004.
39. Davies MJ, Fisher LH, Chegini S, and Craig TJ. A practical approach to allergic rhinitis and sleep disturbance management. Allergy Asthma Proc 27:224-230, 2006.
40. Woods L, and Craig TJ. The importance of rhinitis on sleep, daytime somnolence, productivity and fatigue. Curr Opin Pulm Med 12:390-396, 2006.
41. Vandenplas O, D'Alpaos V, and Van Brussel P. Rhinitis and its impact on work. Curr Opin Allergy Clin Immunol 8:145-149, 2008.
42. Naclerio RM, Hadley JA, Stoloff S, and Nelson HS. Patient and physician perspectives on the attributes of nasal allergy medications. Allergy Asthma Proc 28(suppl):S11-S17, 2007.